[go: up one dir, main page]

FR2925314B1 - Utilisation cosmetique de proteines de type transglutaminase 3 - Google Patents

Utilisation cosmetique de proteines de type transglutaminase 3

Info

Publication number
FR2925314B1
FR2925314B1 FR0759999A FR0759999A FR2925314B1 FR 2925314 B1 FR2925314 B1 FR 2925314B1 FR 0759999 A FR0759999 A FR 0759999A FR 0759999 A FR0759999 A FR 0759999A FR 2925314 B1 FR2925314 B1 FR 2925314B1
Authority
FR
France
Prior art keywords
transglutaminase
proteins
cosmetic use
cosmetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR0759999A
Other languages
English (en)
Other versions
FR2925314A1 (fr
Inventor
Dominique Bernard
Lucie Simonetti
Isabelle Castiel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Priority to FR0759999A priority Critical patent/FR2925314B1/fr
Publication of FR2925314A1 publication Critical patent/FR2925314A1/fr
Application granted granted Critical
Publication of FR2925314B1 publication Critical patent/FR2925314B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6881—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from skin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Birds (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
FR0759999A 2007-12-19 2007-12-19 Utilisation cosmetique de proteines de type transglutaminase 3 Active FR2925314B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR0759999A FR2925314B1 (fr) 2007-12-19 2007-12-19 Utilisation cosmetique de proteines de type transglutaminase 3

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0759999A FR2925314B1 (fr) 2007-12-19 2007-12-19 Utilisation cosmetique de proteines de type transglutaminase 3

Publications (2)

Publication Number Publication Date
FR2925314A1 FR2925314A1 (fr) 2009-06-26
FR2925314B1 true FR2925314B1 (fr) 2012-11-23

Family

ID=39619397

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0759999A Active FR2925314B1 (fr) 2007-12-19 2007-12-19 Utilisation cosmetique de proteines de type transglutaminase 3

Country Status (1)

Country Link
FR (1) FR2925314B1 (fr)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9750674B2 (en) 2010-06-11 2017-09-05 The Procter & Gamble Company Compositions for treating skin
US10942107B2 (en) 2017-12-08 2021-03-09 The Procter & Gamble Company Methods of screening for mild skin cleanser
US10966916B2 (en) 2014-11-10 2021-04-06 The Procter And Gamble Company Personal care compositions
US10987290B2 (en) 2017-10-20 2021-04-27 The Procter And Gamble Company Aerosol foam skin cleanser
US11207261B2 (en) 2014-11-10 2021-12-28 The Procter And Gamble Company Personal care compositions with two benefit phases
US11207248B2 (en) 2014-11-10 2021-12-28 The Procter And Gamble Company Personal care compositions with two benefit phases
US11419805B2 (en) 2017-10-20 2022-08-23 The Procter & Gamble Company Aerosol foam skin cleanser

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9671410B2 (en) 2011-01-16 2017-06-06 The Procter & Gamble Company Biomarker-based methods for identifying and formulating compositions that improve skin quality and reduce the visible signs of aging in skin
US10085924B2 (en) 2014-11-10 2018-10-02 The Procter & Gamble Company Personal care compositions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2796646B1 (fr) * 1999-07-23 2003-10-17 Oreal Polypeptide isole du stratum corneum et son utilisation
EP1384468A1 (fr) * 2002-07-25 2004-01-28 Cognis France S.A. Procédé de protection et modulation des jonctions serrées
EP2500438A3 (fr) * 2002-09-25 2012-11-28 Genentech, Inc. Compositions et procédés nouveaux pour le traitement du psoriasis
FR2857588B1 (fr) * 2003-07-17 2007-11-30 Oreal Utilisation de beta-endorphine, d'agents exercant une activite beta-endorphine-like en cosmetique et dermatologie
FR2877220B1 (fr) * 2004-11-04 2008-10-10 Oreal Utilisation de composes d'uree pour lutter contre les signes du vieillissement cutane
CA2608021A1 (fr) * 2005-05-10 2006-11-16 Dermipsor Ltd. Compositions et procedes de soin de la peau

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9750674B2 (en) 2010-06-11 2017-09-05 The Procter & Gamble Company Compositions for treating skin
US10588838B2 (en) 2010-06-11 2020-03-17 The Procter & Gamble Company Compositions for treating skin
US10966916B2 (en) 2014-11-10 2021-04-06 The Procter And Gamble Company Personal care compositions
US11207261B2 (en) 2014-11-10 2021-12-28 The Procter And Gamble Company Personal care compositions with two benefit phases
US11207248B2 (en) 2014-11-10 2021-12-28 The Procter And Gamble Company Personal care compositions with two benefit phases
US10987290B2 (en) 2017-10-20 2021-04-27 The Procter And Gamble Company Aerosol foam skin cleanser
US11419805B2 (en) 2017-10-20 2022-08-23 The Procter & Gamble Company Aerosol foam skin cleanser
US10942107B2 (en) 2017-12-08 2021-03-09 The Procter & Gamble Company Methods of screening for mild skin cleanser

Also Published As

Publication number Publication date
FR2925314A1 (fr) 2009-06-26

Similar Documents

Publication Publication Date Title
FR2925312B1 (fr) Utilisation cosmetique de proteines de type desmogleine i
FR2924946B1 (fr) Utilisation cosmetique de proteines de type ceramidase acide
FR2917629B1 (fr) Utilisation cosmetique de proteines de type apolipoproteine d
FR2925314B1 (fr) Utilisation cosmetique de proteines de type transglutaminase 3
FR2924613B1 (fr) Utilisation cosmetique de proteines de type hsp27.
BRPI0915825A2 (pt) proteínas de ligação à prostaglandina e2 usos das mesmas
DK3118221T3 (da) Proteiner
BRPI0811637A2 (pt) Proteínas de fusão da imunoglobina
DK2242393T3 (da) Hårstylinghjælpemiddel
DE502007001405D1 (de) Haarpflegezusammensetzung
EP1857091A4 (fr) Cosmetique
BRPI0917027A2 (pt) composição de condicionador de cabelo
EP2172198A4 (fr) INDUCTEUR DE PROTÉINE p27
FR2924947B1 (fr) Utilisation cosmetique de proteines de type calmodulin-like skin protein clsp
EP2007884A4 (fr) Proteines de fusion enzymatiques et leur utilisation
EP2306836A4 (fr) Modulateurs de l expression de la protéine bmi-1
ATE438379T1 (de) Verwendung von haarpflegezusammensetzungen zur konditionierung gebleichter haare
BRPI0819299A2 (pt) Uso de composição, e, composição contendo proteína
BRPI0814971A2 (pt) Proteína
FR2924614B1 (fr) Utilisation cosmetique de proteines de type calgranuline a.
ES1065707Y (es) Aplicador cosmetico
ATE472317T1 (de) Kosmetische verwendung von molkeproteinmizellen
EP2170373A4 (fr) Thermostabilisation de protéines
UY3638Q (es) Secador manual de cabello
DK1833495T3 (da) Dermatologisk anvendelse af mælkeproteiner

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 13

PLFP Fee payment

Year of fee payment: 14

PLFP Fee payment

Year of fee payment: 15

PLFP Fee payment

Year of fee payment: 16

PLFP Fee payment

Year of fee payment: 17

PLFP Fee payment

Year of fee payment: 18

PLFP Fee payment

Year of fee payment: 19